Membrane Oxygenators Market Size & Share 2026-2035

Membrane Oxygenators Market Size

The global membrane oxygenators market was valued at USD 133.8 million in 2025. The market is expected to grow from USD 135.9 million in 2026 to USD 167.5 million in 2035, growing at a CAGR of 2.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

Membrane oxygenators are medical devices used in extracorporeal life support to facilitate gas exchange by removing carbon dioxide and delivering oxygen to the blood. Utilizing advanced membrane technologies like hollow fibers or flat sheets, they are essential in managing respiratory and cardiac failures, especially during ECMO procedures and critical care interventions.
 

The key players in the membrane oxygenators market are abbvie, Abbott, LivaNova, Medtronic, MicroPort, and NIPRO. These players compete in the market through continuous product innovation, strategic mergers and acquisitions, geographic expansion, and investments in advanced technologies, while also focusing on clinical collaborations and regulatory approvals to strengthen their global market presence.
 

The market increased from USD 128 million in 2022 to USD 132.1 million in 2024, with a historic growth rate of 1.6%. The market has shown steady expansion in recent years, driven by the growing demand for extracorporeal membrane oxygenation (ECMO).
 

The growing utilization of ECMO therapy in critical care, particularly during emergencies like acute myocardial infarctions or post-transplant complications, is driving demand for life-supporting respiratory interventions. Moreover, increased healthcare spending in developing nations, coupled with the expansion of advanced healthcare infrastructure, has further propelled market growth. Government initiatives to improve healthcare access and increase training for ECMO deployment are also encouraging the use of membrane oxygenators.
 

Additionally, the development of portable and user-friendly systems is expanding the application of these devices in neonatal and pediatric care. With these innovations and an emphasis on improving patient outcomes, the membrane oxygenators market is poised for substantial growth over the coming years.
 

Membrane Oxygenators Market Trends

The rising prevalence of cardiovascular diseases (CVDs) is a significant driver of the global membrane oxygenators industry. CVDs, including coronary artery disease, heart failure, and myocardial infarction, have become leading causes of mortality worldwide.
 

• This surge in CVD cases necessitates the adoption of advanced medical technologies, such as membrane oxygenators, to support patients requiring extracorporeal membrane oxygenation (ECMO) therapy. Membrane oxygenators play a crucial role in oxygenating blood and removing carbon dioxide during cardiac surgeries, organ transplants, and emergency interventions like cardiogenic shock, thereby improving patient survival and recovery.
   
• The growing demand for life-supporting interventions in cardiac care, especially during high-risk surgeries or in critical conditions such as acute myocardial infarction and post-transplant complications, further fuels market growth.
   
• Additionally, increasing healthcare investments and the expansion of advanced cardiac care infrastructure are facilitating wider access to these essential life-saving devices.
   

Membrane Oxygenators Market Analysis

Based on type, the market is segmented into hollow fiber membrane oxygenators and flat sheet membrane oxygenators. The hollow fiber membrane oxygenators segment is expected to drive business growth and expand at a CAGR of 2.7%, reaching over USD 103.9 million by 2035, driven by the increasing number of cardiopulmonary bypass procedures and the growing demand for efficient oxygen exchange systems in cardiac and respiratory support treatments.
 

• The segment is set to drive market growth due to its superior efficiency and widespread use in critical care. Hollow fiber membranes enable enhanced gas exchange, while the compact design suits ECMO procedures in emergencies like ARDS and cardiogenic shock. 
   
• Additionally, technological advancements in hollow fiber membranes, such as improved biocompatibility and reduced blood trauma, enhance their performance and safety, further boosting demand. These oxygenators are particularly favored in neonatal and pediatric care due to their adaptability for smaller patients.
   
• The flat sheet membrane oxygenators segment was valued at USD 53.6 million in 2025 and is expected to reach USD 63.7 million by 2035. The segment is expected to witness steady growth due to its reliable performance in oxygen transfer during extracorporeal circulation procedures. Additionally, continued use in specific clinical settings and improvements in membrane technology are supporting the gradual expansion of this segment.
   

Based on application, the membrane oxygenators market is segmented into respiratory, cardiac, and extra corporeal cardiopulmonary resuscitation. The respiratory segment is expected to drive business growth and expand at a CAGR of 2.1%, reaching over USD 74.4 million by 2035.
 

• The segment is a key driver in the market, attributed to the rising prevalence of respiratory disorders and increasing adoption of extracorporeal membrane oxygenation (ECMO) therapy.
   
• Conditions such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and pneumonia are becoming more common globally due to factors like aging populations, air pollution, and smoking. For instance, according to the WHO 2024, currently, 64 million people have COPD, and 3 million people die of COPD. These conditions often lead to severe respiratory failure, necessitating the use of advanced oxygenation systems like membrane oxygenators.
   
• The cardiac segment was valued at USD 45.5 million in 2025 and is expected to reach USD 56.6 million by 2035, growing at a CAGR of 2.3% during the forecast period. The growth is driven by the increasing number of cardiac surgeries requiring cardiopulmonary bypass support. Additionally, the rising prevalence of cardiovascular diseases and advancements in cardiac surgical procedures are contributing to the steady demand for membrane oxygenators in this segment.
   
• The extra corporeal cardiopulmonary resuscitation segment was valued at USD 27.3 million in 2025 and is expected to reach USD 36.5 million by 2035. The segment is expanding due to the growing adoption of extracorporeal life support systems for managing severe cardiac and respiratory failure. Increasing use of ECPR in emergency and critical care settings is further supporting the growth of this segment.
   

Based on age group, the membrane oxygenators market is segmented into adults, neonates, and pediatrics. The adults segment is expected to drive business growth and expand at a CAGR of 2.8%, reaching over USD 112.1 million by 2035.
 

• Adults, particularly those aged 50 and above, represent a substantial proportion of the global population suffering from respiratory and cardiovascular diseases. Conditions such as COPD, acute respiratory distress syndrome (ARDS), and cardiogenic shock are more prevalent in this demographic, necessitating the use of advanced extracorporeal life-support systems, including membrane oxygenators.
   
• Furthermore, the rising incidence of lifestyle-related disorders, such as hypertension, diabetes, and obesity, which are risk factors for cardiac and respiratory conditions, further drives demand for oxygenation devices in adults.
   
• The neonates segment was valued at USD 31.4 million in 2025 and is expected to reach USD 36.6 million by 2035, growing at a CAGR of 1.6% during the forecast period. The growth is driven by the increasing number of neonatal cardiac and respiratory procedures requiring extracorporeal support. Additionally, advancements in neonatal intensive care units and specialized oxygenation technologies are supporting the adoption of membrane oxygenators in this segment.
   
• The pediatrics segment was valued at USD 17 million in 2025 and is expected to reach USD 18.9 million by 2035. The segment is witnessing steady growth due to the rising incidence of congenital heart defects and pediatric respiratory disorders. Growing availability of pediatric-specific cardiopulmonary support devices and improvements in pediatric cardiac surgery outcomes are further contributing to market expansion.

Based on end use, the membrane oxygenators market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 44.1% in 2025.
 

• Hospitals are primary centers for critical care and advanced medical interventions, making them essential users of membrane oxygenators. These devices are critical in managing life-threatening conditions such as ARDS, cardiogenic shock, and post-cardiac surgery complications. The increasing number of cardiovascular and respiratory disease cases globally has significantly boosted demand for extracorporeal membrane oxygenation (ECMO) procedures in hospitals, where membrane oxygenators play a vital role.
   
• Moreover, hospitals are equipped with specialized infrastructure and highly trained medical staff to perform complex procedures requiring membrane oxygenators. The integration of advanced ECMO systems in intensive care units (ICUs) enhances patient outcomes, further driving demand in this segment. The rising prevalence of high-risk surgeries, organ transplants, and neonatal care cases requiring oxygenation support contributes to the growth of the hospital segment.
   
• The ambulatory surgical centers segment was valued at USD 45 million in 2025 and is expected to reach USD 54.7 million by 2035, growing at a CAGR of 2.1% during the forecast period. The growth is supported by the increasing number of minimally invasive cardiac and thoracic procedures performed in outpatient settings. Additionally, the adoption of compact and efficient extracorporeal circulation systems in ambulatory facilities is contributing to segment expansion.
   
• The other end users segment is expected to witness steady growth over the forecast period, driven by the increasing use of membrane oxygenators in specialty care centers, research institutions, and emergency care facilities. Expanding healthcare infrastructure and rising demand for advanced cardiopulmonary support technologies are further supporting the gradual growth in this segment.

North America Membrane Oxygenators Market

North America dominated the global membrane oxygenators industry, accounting for over 35.2% share in 2025.
 

• The U.S. market was valued at USD 43.6 million and USD 44.1 million in 2022 and 2023, respectively. The market size reached USD 44.4 million in 2025, growing from USD 44.2 million in 2024, and is anticipated to grow at a CAGR of 1.5% from 2026 to 2035.
   
• The growing prevalence of respiratory and cardiovascular conditions like ARDS and cardiogenic shock, coupled with an aging U.S. population prone to chronic illnesses, is driving the demand for ECMO procedures where membrane oxygenators are essential.
   
• A well-established healthcare infrastructure, increasing ECMO centers, and technological advancements in portable and efficient oxygenators further enhance their adoption, especially in neonatal and pediatric care.
   

Europe Membrane Oxygenators Market

The Europe market accounted for USD 36.8 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Europe holds a significant share in the membrane oxygenators market, supported by the strong presence of advanced healthcare infrastructure and a high number of cardiac and cardiopulmonary surgeries performed across the region. Countries such as Germany, the UK, France, and Italy contribute substantially to market growth due to the increasing prevalence of cardiovascular and respiratory diseases. Additionally, the availability of specialized cardiac care centers and the adoption of advanced extracorporeal circulation technologies are supporting the expansion of the market in Europe.
   
• Furthermore, rising investments in healthcare modernization and the presence of leading medical device manufacturers are contributing to technological advancements in oxygenation systems. The growing elderly population, which is more prone to cardiac complications, is also driving demand for membrane oxygenators in the region.
   

Asia Pacific Membrane Oxygenators Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 3.3% during the forecast period.
 

• Asia Pacific is expected to witness steady growth in the membrane oxygenators market, driven by the increasing prevalence of cardiovascular diseases and expanding healthcare infrastructure in emerging economies. Countries such as China, India, Japan, and South Korea are experiencing rising demand for advanced cardiac surgical procedures, which is supporting the adoption of membrane oxygenators.
   
• Additionally, increasing healthcare expenditure and government initiatives aimed at improving access to critical care services are contributing to market growth in the region. The rapid expansion of hospitals and cardiac care centers, along with growing awareness about advanced life support technologies, is further driving the adoption of membrane oxygenators across the Asia Pacific.
   

Latin America Membrane Oxygenators Market

The Latin America market accounted for USD 8.9 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Latin America accounts for a moderate share of the membrane oxygenators market, with countries such as Brazil, Mexico, and Argentina leading regional growth. The rising incidence of cardiovascular disorders and improving healthcare infrastructure are key factors supporting the demand for advanced cardiopulmonary support devices in the region.
   
• Moreover, increasing investments in healthcare facilities and the gradual adoption of advanced surgical technologies are contributing to the expansion of the membrane oxygenators industry. Growing awareness regarding critical care management and improvements in cardiac treatment services are also supporting market development in Latin America.
   

Middle East and Africa Membrane Oxygenators Market

The Middle East and Africa membrane oxygenators industry accounted for USD 5.1 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The Middle East & Africa region is witnessing gradual growth in the membrane oxygenators market, driven by increasing healthcare investments and the expansion of advanced medical facilities in countries such as the UAE, Saudi Arabia, and South Africa. The rising burden of cardiovascular diseases and the growing demand for improved cardiac care services are supporting the adoption of membrane oxygenators in the region.
   
• Additionally, government initiatives to strengthen healthcare infrastructure and the development of specialized cardiac centers are contributing to market growth. Although limited access to advanced medical technologies in certain areas may restrain expansion, ongoing healthcare development programs are expected to create growth opportunities in the MEA market.
   

Membrane Oxygenators Market Share

The membrane oxygenators industry is highly dynamic, with key players like Abbott, LivaNova, Medtronic, MicroPort, and NIPRO, which collectively hold approximately 40% of the total market share. The global market for membrane oxygenators features a mix of established players and emerging manufacturers, competing in a dynamic landscape driven by innovation and demand for advanced extracorporeal life-support systems.  Market share is further influenced by strategic initiatives such as product launches, collaborations, and geographic expansion. Local manufacturers are gaining traction in cost-sensitive regions by offering affordable, high-quality products.
 

Membrane Oxygenators Market Companies

A few of the prominent players operating in the membrane oxygenators industry include:

• Abbott
• BRAILE
• chalice
• CytoSorbents
• EUROSETS
• Fresenius
• GETINGE
• LivaNova
• Medtronic
• MicroPort
• NIPRO
• PrecisionMedical
• RECTUS MEDICAL
• TERUMO
• XENIOS
   
• Abbott

Abbott strengthens its position in the membrane oxygenators market through its broad cardiovascular care ecosystem and strong presence in cardiopulmonary and critical‑care solutions, enabling seamless integration with extracorporeal life‑support workflows. Its competitive advantage is reinforced by a diversified cardiac device portfolio, advanced biomaterials expertise, and continuous innovation aligned with rising cardiovascular disease prevalence and growing ECMO adoption. Abbott’s established U.S. and global distribution channels, high clinical trust, and focus on device performance, safety, and regulatory compliance support consistent demand across hospitals and surgical centers.
 

• Medtronic

Medtronic commands a leading role in the membrane oxygenators and ECMO ecosystem through its highly advanced extracorporeal support systems, including the next‑generation VitalFlow ECMO system, designed for portability, ease of use, and improved clinical efficiency. Its integration of optimized centrifugal pumps, enhanced hemocompatible coatings, user‑centric consoles, and modular components delivers superior physiological support with reduced blood trauma and improved mobility in critical‑care environments. Medtronic’s acquisition‑driven innovation, strong regulatory approvals, and global market reach further solidify its leadership as ECMO therapy adoption accelerates across cardiac, respiratory, and transplant care.
 

The membrane oxygenators market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hollow fiber membrane oxygenators
• Flat sheet membrane oxygenators

Market, By Application

• Respiratory
  • Respiratory failure
  • Pulmonary embolism
  • Acute respiratory distress syndrome
  • Pneumonia
• Cardiac
  • Decompensated cardiomyopathy
  • Acute myocardial infarction
  • Cardiogenic shock
  • Post-transplant complications
  • Myocarditis
• Extra corporeal cardiopulmonary resuscitation

Market, By Age Group

• Adults
• Neonates
• Pediatrics

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE